PBM Capital Group

PBM Capital Group is a private investment firm headquartered in Charlottesville, Virginia, that focuses on the healthcare, life science, health technology, and agriculture technology sectors. Founded in 2010, the firm invests across all stages of corporate development, including venture capital, leveraged buyouts, growth capital, distressed and turnaround opportunities, and public equity. It applies deep industry knowledge and extensive contacts to create value, offering operational expertise and an entrepreneurial approach to its portfolio companies. The firm partners closely with its investments to drive commercial success and improve profitability.

Manning, Paul B.

Chairman and CEO

Joe Pedersen

Partner

Jayson Rieger

Managing Partner

Sean Stalfort

President

Past deals in Virginia

Landos Biopharma

Series B in 2019
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company based in Blacksburg, Virginia, focused on developing innovative oral therapeutics for autoimmune diseases, particularly inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis. Founded in 2017, the company aims to address unmet medical needs through its unique approach to treatment, leveraging novel mechanisms of action. Its lead product candidate, NX-13, is a gut-selective NLRX1 agonist designed to modulate immune responses, and it is part of a broader pipeline that includes other internally discovered compounds targeting various pathways at the intersection of immunity and metabolism. Landos Biopharma's commitment to developing first-in-class therapeutics underscores its dedication to improving patient outcomes in the field of autoimmune disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.